Validation of the Paper Pull Test for 1st Metatarsophalangeal Strength in Patients with Hallux Valgus and Healthy Controls

Purpose: Explore the validity of the paper pull test (PPT) intrinsic muscle function

Current Status of Fungal and Viral Infections of the Peaks of Otter Salamander and Other Amphibians in Virginia

Undergraduate Basi

Baguette:towards end-to-end service orchestration in heterogeneous networks

Network services are the key mechanism for operators to introduce intelligence and generate profit from their infrastructures. The growth of the number of network users and the stricter application network requirements have highlighted a number of challenges in orchestrating services using existing production management and configuration protocols and mechanisms. Recent networking paradigms like Software Defined Networking (SDN) and Network Function Virtualization (NFV), provide a set of novel control and management interfaces that enable unprecedented automation, flexibility and openness capabilities in operator infrastructure management. This paper presents Baguette, a novel and open service orchestration framework for operators. Baguette supports a wide range of network technologies, namely optical and wired Ethernet technologies, and allows service providers to automate the deployment and dynamic re-optimization of network services. We present the design of the orchestrator and elaborate on the integration of Baguette with existing low-level network and cloud management frameworks

From Mantle to Motzfeldt : a genetic model for syenite-hosted Ta,Nb-mineralisation

This research summarises many years of field and lab studies on the area, but the most recent work (2016) has received funding from the European Union’s Horizon 2020 research and innovation programme (grant agreement No 689909).A genetic model for the Motzfeldt Tantalum-Niobium-rich syenite in south-west Greenland, considered to be one of the world’s largest Ta prospects, is presented. The Motzfeldt primary magma formed early in regional Gardar (1273 ± 6 Ma) rifting. Isotope signatures indicate that the Hf had multiple sources involving juvenile Gardar Hf mixed with older (Palaeoproterozoic or Archaean) Hf. We infer that other High Field Strength Elements (HFSE) similarly had multiple sources. The magma differentiated in the crust and ascended before emplacement at the regional unconformity between Ketilidian basement and Eriksfjord supracrustals. The HFSE-rich magmas crystallised Ta-rich pyrochlore which formed pyrochlore-rich crystal mushes, and it is these pyrochlore-rich horizons, rich in Ta and Nb, that are the focus of exploration. The roof zone chilled and repeated sheeting at the roof provided a complex suite of cross-cutting syenite variants, including pyrochlore microsyenite, in a ‘Hot Sheeted Roof’ model. The area was subject to hydrothermal alteration which recrystallized alkali feldspar to coarse perthite and modified the mafic minerals to hematite, creating the friable and striking pink-nature of the Motzfeldt Sø Centre. Carbon and oxygen isotope investigation of carbonate constrains fluid evolution and shows that carbonate is primarily mantle-derived but late-stage hydrothermal alteration moved the oxygen isotopes towards more positive values (up to 21‰). The hydrothermal fluid was exceptionally fluorine-rich and mobilised many elements including U and Pb but did not transport HFSE such as Ta, Hf and Nb. Although the U and Pb content of the pyrochlore was enhanced by the fluid, the HFSE contents remained unchanged and therefore Hf isotopes were unaffected by fluid interaction. While the effect on hydrothermal alteration on the visual appearance of the rock is striking, magmatic processes concentrated HFSE including Ta and the hydrothermal phase has not altered the grade. Exploration for HFSE mineralisation commonly relies on airborne radiometric surveying which is particularly sensitive to the presence of U, Th. A crucial lesson from Motzfeldt is that the best target is unaltered pyrochlore which was identified less easily by radiometric survey. Careful petrological/mineral studies are necessary before airborne survey data can be fully interpreted.PreprintPostprintPeer reviewe

Brain Biomarkers and Pre-Injury Cognition are Associated with Long-Term Cognitive Outcome in Children with Traumatic Brain Injury

BACKGROUND: Children with traumatic brain injury (TBI) are frequently at risk of long-term impairments of attention and executive functioning but these problems are difficult to predict. Although deficits have been reported to vary with injury severity, age at injury and sex, prognostication of outcome remains imperfect at a patient-specific level. The objective of this proof of principle study was to evaluate a variety of patient variables, along with six brain-specific and inflammatory serum protein biomarkers, as predictors of long-term cognitive outcome following paediatric TBI. METHOD: Outcome was assessed in 23 patients via parent-rated questionnaires related to attention deficit hyperactivity disorder (ADHD) and executive functioning, using the Conners 3rd Edition Rating Scales (Conners-3) and Behaviour Rating Inventory of Executive Function (BRIEF) at a mean time since injury of 3.1 years. Partial least squares (PLS) analyses were performed to identify factors measured at the time of injury that were most closely associated with outcome on (1) the Conners-3 and (2) the Behavioural Regulation Index (BRI) and (3) Metacognition Index (MI) of the BRIEF. RESULTS: Higher levels of neuron specific enolase (NSE) and lower levels of soluble neuron cell adhesion molecule (sNCAM) were associated with higher scores on the inattention, hyperactivity/impulsivity and executive functioning scales of the Conners-3, as well as working memory and initiate scales of the MI from the BRIEF. Higher levels of NSE only were associated with higher scores on the inhibit scale of the BRI. CONCLUSIONS: NSE and sNCAM show promise as reliable, early predictors of long-term attention-related and executive functioning problems following paediatric TBI

Network service orchestration standardization:a technology survey

Network services underpin operator revenues, and value-added services provide income beyond core (voice and data) infrastructure capability. Today, operators face multiple challenges: a need to innovate and offer a wider choice of value-added services, whilst increasing network scale, bandwidth and flexibility. They must also reduce operational costs, and deploy services far faster - in minutes rather than days or weeks. In the recent years, the network community, motivated by the aforementioned challenges, has developed production network architectures and seeded technologies, like Software Defined Networking, Application-based Network Operations and Network Function Virtualization. These technologies enhance the highly desired properties for elasticity, agility and cost-effectiveness in the operator environment. A key requirement to fully exploit the benefits of these new architectures and technologies is a fundamental shift in management and control of resources, and the ability to orchestrate the network infrastructure: coordinate the instantiation of high-level network services across different technological domains and automate service deployment and re-optimization. This paper surveys existing standardization efforts for the orchestration - automation, coordination, and management - of complex set of network and function resources (both physical and virtual), and highlights the various enabling technologies, strengths and weaknesses, adoption challenges for operators, and areas where further research is required

The chlorite proximitor: A new tool for detecting porphyry ore deposits

publisher: Elsevier articletitle: The chlorite proximitor: A new tool for detecting porphyry ore deposits journaltitle: Journal of Geochemical Exploration articlelink: http://dx.doi.org/10.1016/j.gexplo.2015.01.005 content_type: article copyright: Crown copyright © 2015 Published by Elsevier B.V.Copyright © 2016 Elsevier B.V. or its licensors or contributors. ScienceDirect ® is a registered trademark of Elsevier B.V. [Creative Commons License 4.0]. The attached file is the published version of the article

Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial

Background Findings from the RESTART trial suggest that starting antiplatelet therapy might reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding antiplatelet therapy. Brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases (such as cerebral microbleeds) are associated with greater risks of recurrent intracerebral haemorrhage. We did subgroup analyses of the RESTART trial to explore whether these brain imaging features modify the effects of antiplatelet therapy

Reverberation mapping of optical emission lines in five active galaxies

For a video summarizing the main results, see https://www.youtube.com/watch?v=KaC-jPsIY0QWe present the first results from an optical reverberation mapping campaign executed in 2014 targeting the active galactic nuclei (AGNs) MCG+08-11-011, NGC 2617, NGC 4051, 3C 382, and Mrk 374. Our targets have diverse and interesting observational properties, including a "changing look" AGN and a broad-line radio galaxy. Based on continuum-Hβ lags, we measure black hole masses for all five targets. We also obtain Hγ and He ii λ4686 lags for all objects except 3C 382. The He ii λ4686 lags indicate radial stratification of the BLR, and the masses derived from different emission lines are in general agreement. The relative responsivities of these lines are also in qualitative agreement with photoionization models. These spectra have extremely high signal-to-noise ratios (100–300 per pixel) and there are excellent prospects for obtaining velocity-resolved reverberation signatures.Publisher PDFPeer reviewe

Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial

Background: Antiplatelet therapy reduces the risk of major vascular events for people with occlusive vascular disease, although it might increase the risk of intracranial haemorrhage. Patients surviving the commonest subtype of intracranial haemorrhage, intracerebral haemorrhage, are at risk of both haemorrhagic and occlusive vascular events, but whether antiplatelet therapy can be used safely is unclear. We aimed to estimate the relative and absolute effects of antiplatelet therapy on recurrent intracerebral haemorrhage and whether this risk might exceed any reduction of occlusive vascular events. Methods: The REstart or STop Antithrombotics Randomised Trial (RESTART) was a prospective, randomised, open-label, blinded endpoint, parallel-group trial at 122 hospitals in the UK. We recruited adults (≥18 years) who were taking antithrombotic (antiplatelet or anticoagulant) therapy for the prevention of occlusive vascular disease when they developed intracerebral haemorrhage, discontinued antithrombotic therapy, and survived for 24 h. Computerised randomisation incorporating minimisation allocated participants (1:1) to start or avoid antiplatelet therapy. We followed participants for the primary outcome (recurrent symptomatic intracerebral haemorrhage) for up to 5 years. We analysed data from all randomised participants using Cox proportional hazards regression, adjusted for minimisation covariates. This trial is registered with ISRCTN (number ISRCTN71907627). Findings: Between May 22, 2013, and May 31, 2018, 537 participants were recruited a median of 76 days (IQR 29–146) after intracerebral haemorrhage onset: 268 were assigned to start and 269 (one withdrew) to avoid antiplatelet therapy. Participants were followed for a median of 2·0 years (IQR [1·0– 3·0]; completeness 99·3%). 12 (4%) of 268 participants allocated to antiplatelet therapy had recurrence of intracerebral haemorrhage compared with 23 (9%) of 268 participants allocated to avoid antiplatelet therapy (adjusted hazard ratio 0·51 [95% CI 0·25–1·03]; p=0·060). 18 (7%) participants allocated to antiplatelet therapy experienced major haemorrhagic events compared with 25 (9%) participants allocated to avoid antiplatelet therapy (0·71 [0·39–1·30]; p=0·27), and 39 [15%] participants allocated to antiplatelet therapy had major occlusive vascular events compared with 38 [14%] allocated to avoid antiplatelet therapy (1·02 [0·65–1·60]; p=0·92). Interpretation: These results exclude all but a very modest increase in the risk of recurrent intracerebral haemorrhage with antiplatelet therapy for patients on antithrombotic therapy for the prevention of occlusive vascular disease when they developed intracerebral haemorrhage. The risk of recurrent intracerebral haemorrhage is probably too small to exceed the established benefits of antiplatelet therapy for secondary prevention